|
US6890951B2
(en)
|
1998-08-05 |
2005-05-10 |
Brookhaven Science Associates Llc |
Treatment of addiction and addiction-related behavior
|
|
JP2002537326A
(ja)
*
|
1999-02-24 |
2002-11-05 |
ユニヴァーシティ・オブ・シンシナティ |
衝動調節障害の治療のためのスルファメート誘導体の使用
|
|
JP4709392B2
(ja)
*
|
1999-04-08 |
2011-06-22 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
血液グルコースレベルを下げることに有用な抗痙攣薬誘導体
|
|
NZ514811A
(en)
*
|
1999-04-08 |
2005-01-28 |
Ortho Mcneil Pharm Inc |
Anticonvulsant derivatives useful in reducing blood glucose levels
|
|
JP2003530300A
(ja)
*
|
1999-04-08 |
2003-10-14 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
体重低下を維持することに有用な抗痙攣薬誘導体
|
|
MXPA01010218A
(es)
*
|
1999-04-08 |
2002-03-27 |
Johnson & Johnson |
Derivados anticonvulsivos utiles para disminuir lipidos.
|
|
JP4825353B2
(ja)
*
|
1999-04-08 |
2011-11-30 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
血圧を下げることに有用な抗痙攣薬誘導体
|
|
US20080255093A1
(en)
*
|
1999-06-14 |
2008-10-16 |
Tam Peter Y |
Compositions and methods for treating obesity and related disorders
|
|
US7056890B2
(en)
*
|
1999-06-14 |
2006-06-06 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
US7553818B2
(en)
*
|
1999-06-14 |
2009-06-30 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
US7674776B2
(en)
*
|
1999-06-14 |
2010-03-09 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
US7659256B2
(en)
*
|
1999-06-14 |
2010-02-09 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
US20080103179A1
(en)
*
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
|
DK1309324T3
(da)
|
2000-07-07 |
2006-06-12 |
Ortho Mcneil Pharm Inc |
Antikonvulsive derivater egnede til behandling og forebyggelse af udvikling af type II diabetes mellitus og syndrom X
|
|
US6946243B2
(en)
|
2000-07-20 |
2005-09-20 |
Solvay Pharmaceuticals Gmbh |
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
|
|
DE10035227A1
(de)
*
|
2000-07-20 |
2002-01-31 |
Solvay Pharm Gmbh |
Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind
|
|
ES2269297T3
(es)
*
|
2000-10-30 |
2007-04-01 |
Ortho-Mcneil Pharmaceutical, Inc. |
Combinacion terapeutica que contiene agentes antidiabeticos y anticonvulsivos.
|
|
DE60142632D1
(de)
|
2000-11-30 |
2010-09-02 |
Novodermix Internat Ltd |
Heilung von wunden
|
|
US6462084B1
(en)
|
2001-05-14 |
2002-10-08 |
Brookhaven Science Associates, Llc |
Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
|
|
US6559293B1
(en)
*
|
2002-02-15 |
2003-05-06 |
Transform Pharmaceuticals, Inc. |
Topiramate sodium trihydrate
|
|
US20050025791A1
(en)
*
|
2002-06-21 |
2005-02-03 |
Julius Remenar |
Pharmaceutical compositions with improved dissolution
|
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
|
AU2003213719A1
(en)
|
2002-03-01 |
2003-09-16 |
Regents Of The University Of Michigan |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
|
US20040029941A1
(en)
*
|
2002-05-06 |
2004-02-12 |
Jennings Julianne E. |
Zonisamide use in obesity and eating disorders
|
|
US20050215552A1
(en)
*
|
2002-05-17 |
2005-09-29 |
Gadde Kishore M |
Method for treating obesity
|
|
EP2301537A1
(en)
|
2002-05-17 |
2011-03-30 |
Duke University |
Zonisamide for the treatment of obesity
|
|
US20070059356A1
(en)
*
|
2002-05-31 |
2007-03-15 |
Almarsson Oern |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
US7208477B2
(en)
*
|
2002-12-02 |
2007-04-24 |
University Of Florida Research Foundation, Inc. |
Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases
|
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
|
SI2316456T1
(sl)
|
2003-04-29 |
2017-10-30 |
Orexigen Therapeutics, Inc. |
Sestavki za vplivanje na izgubo teže, ki obsegajo opioidni antagonist in bupropion
|
|
US6949518B1
(en)
|
2003-06-25 |
2005-09-27 |
Pao-Hsien Chu |
Methods for treating macular degeneration with topiramate
|
|
US7713959B2
(en)
*
|
2004-01-13 |
2010-05-11 |
Duke University |
Compositions of an anticonvulsant and mirtazapine to prevent weight gain
|
|
US20060160750A1
(en)
*
|
2004-01-13 |
2006-07-20 |
Krishnan K R R |
Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss
|
|
WO2005070461A2
(en)
|
2004-01-13 |
2005-08-04 |
Duke University |
Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss
|
|
US20060100205A1
(en)
*
|
2004-04-21 |
2006-05-11 |
Eckard Weber |
Compositions for affecting weight loss
|
|
CN1968692A
(zh)
*
|
2004-05-03 |
2007-05-23 |
杜克大学 |
影响体重减轻的组合物
|
|
MY147767A
(en)
*
|
2004-06-16 |
2013-01-31 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
|
TW200612905A
(en)
*
|
2004-06-16 |
2006-05-01 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
|
AU2005277134A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Janssen Pharmaceutica N.V. |
Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
|
|
WO2006127184A1
(en)
*
|
2005-05-20 |
2006-11-30 |
Janssen Pharmaceutica N.V. |
Process for preparation of sulfamide derivatives
|
|
EP2135603B1
(en)
|
2005-11-22 |
2013-01-02 |
Orexigen Therapeutics, Inc. |
Compositions and methods for increasing insulin sensitivity
|
|
WO2007089318A2
(en)
*
|
2005-11-23 |
2007-08-09 |
Orexigen Therapeutics, Inc. |
Compositions and methods for reducing food cravings
|
|
US20070155823A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
|
|
US8691867B2
(en)
|
2005-12-19 |
2014-04-08 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
|
|
US20070155827A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
|
|
US8497298B2
(en)
*
|
2005-12-19 |
2013-07-30 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
|
|
US8716231B2
(en)
*
|
2005-12-19 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
|
|
AR058389A1
(es)
*
|
2005-12-19 |
2008-01-30 |
Janssen Pharmaceutica Nv |
Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
|
|
US8937096B2
(en)
|
2005-12-19 |
2015-01-20 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
|
|
US20070191449A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
|
|
US20070191459A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels
|
|
US20070191474A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
|
|
US20070191461A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
|
|
US20070191453A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction
|
|
AU2007253814A1
(en)
*
|
2006-05-19 |
2007-11-29 |
Janssen Pharmaceutica N.V. |
Co-therapy for the treatment of epilepsy
|
|
US8916195B2
(en)
|
2006-06-05 |
2014-12-23 |
Orexigen Therapeutics, Inc. |
Sustained release formulation of naltrexone
|
|
KR20150082689A
(ko)
|
2006-11-09 |
2015-07-15 |
오렉시젠 세러퓨틱스 인크. |
단위 용량 팩키지
|
|
KR101735466B1
(ko)
|
2006-11-09 |
2017-05-15 |
오렉시젠 세러퓨틱스 인크. |
신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
|
|
US20090247617A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Abdel-Magid Ahmed F |
Process for the preparation of benzo-fused heteroaryl sulfamates
|
|
US20090247616A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
|
|
CA2725930A1
(en)
|
2008-05-30 |
2009-12-30 |
Orexigen Therapeutics, Inc. |
Methods for treating visceral fat conditions
|
|
US8580298B2
(en)
|
2008-06-09 |
2013-11-12 |
Vivus, Inc. |
Low dose topiramate/phentermine composition and methods of use thereof
|
|
US20090304789A1
(en)
|
2008-06-09 |
2009-12-10 |
Thomas Najarian |
Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
|
|
AU2009271362B2
(en)
|
2008-06-23 |
2014-03-13 |
Janssen Pharmaceutica Nv |
Crystalline form of (2s)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
|
|
US8815939B2
(en)
|
2008-07-22 |
2014-08-26 |
Janssen Pharmaceutica Nv |
Substituted sulfamide derivatives
|
|
CN102724878A
(zh)
|
2010-01-11 |
2012-10-10 |
奥雷西根治疗公司 |
在重度抑郁症患者中提供体重减轻疗法的方法
|
|
DK3730132T3
(da)
|
2012-06-06 |
2022-08-08 |
Nalpropion Pharmaceuticals Llc |
Sammensætning til anvendelse ved en fremgangsmåde til behandling af overvægt og obesitas hos patienter med høj kardiovaskulær risiko
|
|
US8652527B1
(en)
|
2013-03-13 |
2014-02-18 |
Upsher-Smith Laboratories, Inc |
Extended-release topiramate capsules
|
|
US9101545B2
(en)
|
2013-03-15 |
2015-08-11 |
Upsher-Smith Laboratories, Inc. |
Extended-release topiramate capsules
|
|
US8969371B1
(en)
|
2013-12-06 |
2015-03-03 |
Orexigen Therapeutics, Inc. |
Compositions and methods for weight loss in at risk patient populations
|
|
US10278948B1
(en)
|
2015-09-03 |
2019-05-07 |
Tian Xia |
Method for transnasal delivery of anticonvulsant and therapeutic treatments
|
